Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Personal Genome Services Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The personal genome services market has expanded significantly in recent years. This market is anticipated to expand from $6.84 billion in 2025 to $7.85 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.7%. The observed growth in prior periods can be attributed to several factors, including the decrease in sequencing expenses, an upswing in the demand for ancestry testing, increased consumer understanding of genetics, the proliferation of genomics startups, and improvements in the precision of sequencing.
The personal genome services market size is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $13.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. Several factors are driving this expansion during the forecast period, including the increasing adoption of preventive genomics, wider application of pharmacogenomics, growing consumer demand for personalized wellness solutions, more extensive insurance coverage for testing, and integration with digital health platforms. Key trends expected during this period encompass direct-to-consumer genome testing, comprehensive health risk genomic reports, bundled pharmacogenomic services, packages for preventive genome screening, and digital platforms for genetic counseling.
Get A Free Sample Report With In-Depth Market Insights:
Personal Genome Services Market Growth Backed By Core Demand Fundamentals
A growing emphasis on personalized medicine is anticipated to drive expansion in the personal genome services market. This medical approach involves tailoring treatment and prevention plans specifically to an individual’s unique genetic, biological, and lifestyle traits. Its adoption is on the rise, spurred by developments in genomics and molecular diagnostics, which enable treatments to be customized according to a person’s genetic makeup, leading to improved results. Personal genome services facilitate personalized medicine through the analysis of an individual’s genetic data to forecast disease susceptibility, inform medication choices, and customize preventative and therapeutic approaches. As an example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA approved 16 novel personalized treatments for rare disease patients in 2023, a notable increase from six such approvals in 2022. Among these newly sanctioned personalized therapies in 2023 were seven medications for cancer and three for various other ailments and conditions. Consequently, the heightened attention on personalized medicine is a key factor propelling the expansion of the personal genome services market.
Personal Genome Services Market Segment Outlook: Which Categories Are Growing Fastest?
The personal genome services market covered in this report is segmented –
1) By Service Type: Genetic Testing; Whole Genome Sequencing; Carrier Testing; Ancestry Testing; Other Service Types
2) By Application: Healthcare; Research; Ancestry; Other Applications
3) By End-User: Hospitals and Clinics; Research Centers; Direct-to-Consumer; Other End-Users
Subsegments:
1) By Genetic Testing: Health Risk Assessment Testing; Pharmacogenomic Testing; Nutritional Genetic Testing; Lifestyle Genetic Testing; Wellness Genetic Screening
2) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; Preventive Health Genome Sequencing; Rare Disease Genome Sequencing; Population Based Genome Sequencing
3) By Carrier Testing: Inherited Disease Carrier Screening; Preconception Carrier Testing; Prenatal Carrier Testing; Reproductive Health Carrier Screening; Family Planning Carrier Testing
4) By Ancestry Testing: Ethnicity Estimation Testing; Genealogical Lineage Testing; Migration Pattern Analysis; Regional Ancestry Breakdown; Family Relationship Discovery
5) By Other Service Types: Newborn Genetic Screening; Predictive Genetic Testing; Sports Performance Genetic Analysis; Personalized Health Reporting; Custom Genetic Consulting Services
Personal Genome Services Market Growth Trends Reshaping The Competitive Landscape
Key players in the personal genome services market are dedicated to developing advanced solutions like genome-wide risk stratification to deliver personalized health insights, foresee disease susceptibility, and guide interventions for prevention and lifestyle. Genome-wide risk stratification describes the process of analyzing an individual’s entire genome to identify genetic variations contributing to the risk of certain diseases or conditions, facilitating personalized health risk predictions and focused preventive strategies. For instance, in November 2025, MyOme Inc., a US-based biotechnology company, launched the first integrated polygenic risk score (iPRS) test for prostate cancer. This test combines approximately ~7 million genetic markers with clinical factors to provide personalized 10-year and lifetime risk estimates, having been validated in over 140,000+ diverse men. Its aim is the early detection and prevention for 95% of cases without rare variants such as BRCA2, informing decisions for PSA, MRI, or biopsies for high-risk individuals (those with 3-4x elevated odds in the top decile) while reducing false positives and overtreatment. The benefits encompass precise stratification, equitable performance across ancestries, and lifelong AI-updated insights from a single whole-genome sample.
Personal Genome Services Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the personal genome services market are Thermo Fisher Scientific Inc, Illumina Inc, Helix OpCo LLC, Ancestry.com Operations Inc, Fulgent Genetics Inc, 23andMe Holding Co, Prenetics Global Limited, MyHeritage Ltd, Color Health Inc, Genomics plc, GenoPalate Inc, Living DNA Ltd, Mapmygenome India Pvt Ltd, Nebula Genomics Inc, Xcode Life Sciences Pvt Ltd, Sema4 Holdings Corp, Gene by Gene Ltd, TellmeGen SL, CRI Genetics LLC, African Ancestry Inc, and DNAFit Limited.
View The Full Personal Genome Services Market Report:
Personal Genome Services Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the personal genome services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personal genome services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
